We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$54.7B
AUM Growth
+$1.45B
(+2.7%)
Cap. Flow
+$1.02B
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
17.33%
Holding
3,009
New
39
Increased
2,170
Reduced
725
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$65.3M |
| 2 |
Global Payments
GPN
|
+$40.3M |
| 3 |
Microsoft
MSFT
|
+$37.9M |
| 4 |
L3Harris
LHX
|
+$32.8M |
| 5 |
Amazon
AMZN
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$64.3M |
| 2 |
RHT
Red Hat Inc
RHT
|
+$57.1M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$40M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$39.2M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.64% |
| 2 | Financials | 15.56% |
| 3 | Healthcare | 12.85% |
| 4 | Consumer Discretionary | 10.31% |
| 5 | Industrials | 10.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Acacia Research
ACTG
$439M
| $214K | ﹤0.01% |
79,811
+6,903
| +9% | +$19.3K |
|
2727
The Joint Corp
JYNT
$118M
| $214K | ﹤0.01% |
11,481
+1,201
| +12% | +$22.2K |
|
|
PVLA
2728
Palvella Therapeutics
PVLA
$2.18B
| $214K | ﹤0.01% |
786
-6
| -0.8% | -$2.32K |
|
|
FCCY
2729
DELISTED
1st Constitution Bancorp
FCCY
| $213K | ﹤0.01% |
11,374
+1,215
| +12% | +$21.7K |
|
|
CLPR
2730
Clipper Realty
CLPR
$43.9M
| $212K | ﹤0.01% |
20,832
-310
| -1% | -$3.39K |
|
|
TNAV
2731
DELISTED
Telenav Inc.
TNAV
| $212K | ﹤0.01% |
44,338
+2,503
| +6% | +$21.1K |
|
|
SCWX
2732
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $210K | ﹤0.01% |
16,213
+1,006
| +7% | +$12.4K |
|
|
PMBC
2733
DELISTED
Pacific Mercantile Bancorp
PMBC
| $209K | ﹤0.01% |
27,773
+2,532
| +10% | +$19.9K |
|
2734
Phreesia
PHR
$698M
| $208K | ﹤0.01% |
+8,588
| New | +$226K |
|
|
ATHX
2735
DELISTED
Athersys, Inc. Common Stock
ATHX
| $208K | ﹤0.01% |
6,248
-17
| -0.3% | -$603 |
|
|
RLH
2736
DELISTED
Red Lions Hotel Corporation
RLH
| $208K | ﹤0.01% |
32,043
+3,079
| +11% | +$19.2K |
|
2737
Evolution Petroleum
EPM
$126M
| $207K | ﹤0.01% |
35,451
+179
| +0.5% | +$1.09K |
|
2738
TSMC
TSM
$2.16T
| $205K | ﹤0.01% |
+4,400
| New | +$188K |
|
|
CMRX
2739
DELISTED
Chimerix, Inc.
CMRX
| $205K | ﹤0.01% |
87,368
+6,380
| +8% | +$18.4K |
|
2740
ADMA Biologics
ADMA
$2.12B
| $204K | ﹤0.01% |
45,841
+16,443
| +56% | +$68.7K |
|
2741
Stagwell
STGW
$2.24B
| $204K | ﹤0.01% |
72,339
-575
| -0.8% | -$1.44K |
|
2742
Replimune Group
REPL
$1B
| $202K | ﹤0.01% |
14,533
-135
| -0.9% | -$1.66K |
|
|
NBEV
2743
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $202K | ﹤0.01% |
73,353
+40
| +0.1% | +$141 |
|
|
VIA
2744
DELISTED
Viacom Inc. Class A
VIA
| $202K | ﹤0.01% |
7,687
-118
| -2% | -$3.67K |
|
2745
Ascent Industries
ACNT
$145M
| $201K | ﹤0.01% |
12,589
+1,176
| +10% | +$18.8K |
|
2746
eGain
EGAN
$196M
| $201K | ﹤0.01% |
25,143
-200
| -0.8% | -$1.53K |
|
|
OPTN
2747
DELISTED
OptiNose
OPTN
| $201K | ﹤0.01% |
1,918
-12
| -0.6% | -$1.2K |
|
|
CNCE
2748
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $200K | ﹤0.01% |
33,984
+2,998
| +10% | +$31.8K |
|
|
ARD
2749
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $200K | ﹤0.01% |
12,747
-70
| -0.5% | -$1.2K |
|
2750
Cue Biopharma
CUE
$116M
| $199K | ﹤0.01% |
788
+8
| +1% | +$1.92K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2019 Portfolio in Review
As of Q3 2019, RhumbLine Advisers held 3,009 positions worth $54.7B, up 2.7% from $53.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 3.1%. RhumbLine Advisers opened 39 new positions and exited 55, leaving the 3,009-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2019 buy was Avantor: 187,780 shares worth $2.76M.
- RhumbLine Advisers added most to Fidelity National Information Services in Q3 2019, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q3 2019 reduction was Leidos, cutting an estimated $15M.
- RhumbLine Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $64.3M.
- RhumbLine Advisers's ten largest holdings make up 17% of its $54.7B portfolio in Q3 2019.
- RhumbLine Advisers opened 39 new positions and closed 55 in Q3 2019.
- RhumbLine Advisers's portfolio value rose 2.7% quarter-over-quarter to $54.7B.
Based on RhumbLine Advisers's 13F filing for Q3 2019, filed 23 Oct 2019.